The Cell Therapy and Regenerative Medicine Program (CellReGen™) at the University of Utah provides hematopoietic stem and progenitor cells to the Huntsman Cancer Institute Transplant and Cellular Therapy Program, Primary Children's Hospital and LDS Hospital in support of:

• Autologous/Allogeneic PBSC Processing, Cryopreservation/Infusion and Storage
• Autologous/Allogeneic Bone Marrow Processing, Cryopreservation/Infusion and Storage
• Cord Blood Processing and Infusion
• Flow Cytometry Analysis for HPC Products
• CD34+ Selection
• HPC Apheresis, MNC Apheresis
• Cellular Immunotherapies
• Commercialized & Clinical Trial CAR-T Therapy
• Cytotoxic T Lymphocyte Therapy